ACQUIREDT+30
Dennis Phillip Andrew
Novabridge Biosciences · NASDAQ
+23,695 sh
Filed 21 Sept 2026SEC Form 4view source
Renaissance Technologies
13F filer
$670.1K
272,412 sh
Cao Sean Wuxiong
US insider
$79.9K
231,394 sh
BlackRock
13F filer
$12.8K
7,684 sh
Dennis Phillip Andrew
US insider
$5.8K
15,486 sh
Xu Cong Claire
US insider
$2.6K
6,100 sh
Lenz Robert A.
US insider
—
17,218 sh
Dennis Phillip Andrew
Novabridge Biosciences · NASDAQ
+23,695 sh
Dennis Phillip Andrew
Novabridge Biosciences · NASDAQ
−8,209 sh · $5.8K
Cao Sean Wuxiong
Novabridge Biosciences · NASDAQ
−107,978 sh · $79.9K
Cao Sean Wuxiong
Novabridge Biosciences · NASDAQ
+104,236 sh
Cao Sean Wuxiong
Novabridge Biosciences · NASDAQ
+235,136 sh
Xu Cong Claire
Novabridge Biosciences · NASDAQ
+9,382 sh
Xu Cong Claire
Novabridge Biosciences · NASDAQ
−3,282 sh · $2.6K
Lenz Robert A.
Novabridge Biosciences · NASDAQ
+17,218 sh
Renaissance Technologies
Novabridge Biosciences · NASDAQ
272,412 sh · $670.1K
BlackRock
Novabridge Biosciences · NASDAQ
7,684 sh · $12.8K